DiaSorin SpA (Germany) Today
| 34D Stock | EUR 104.05 0.95 0.90% |
Performance1 of 100
| Odds Of DistressLess than 9
|
DiaSorin SpA is trading at 104.05 as of the 23rd of November 2024. This is a 0.9% down since the beginning of the trading day. The stock's lowest day price was 104.05. DiaSorin SpA has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for DiaSorin SpA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of November 2023 and ending today, the 23rd of November 2024. Click here to learn more.
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital analysis laboratories worldwide. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy. DIASORIN S operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. The company has 53.84 M outstanding shares. More on DiaSorin SpA
Moving against DiaSorin Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
DiaSorin Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. DiaSorin SpA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding DiaSorin SpA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Carlo Rosa |
| Business Concentration | Diagnostics & Research, Healthcare (View all Sectors) |
DiaSorin SpA (34D) is traded on Frankfurt Exchange in Germany and employs 3,313 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DiaSorin SpA's market, we take the total number of its shares issued and multiply it by DiaSorin SpA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. DiaSorin SpA classifies itself under Healthcare sector and is part of Diagnostics & Research industry. The entity has 53.84 M outstanding shares.
DiaSorin SpA has accumulated about 78.3 M in cash with 400.66 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.43.
Check DiaSorin SpA Probability Of Bankruptcy
Ownership AllocationDiaSorin SpA holds a total of 53.84 Million outstanding shares. DiaSorin SpA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check DiaSorin Ownership Details
DiaSorin SpA Risk Profiles
Although DiaSorin SpA's alpha and beta are two of the key measurements used to evaluate DiaSorin SpA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.21 | |||
| Semi Deviation | 1.37 | |||
| Standard Deviation | 1.72 | |||
| Variance | 2.97 |
DiaSorin Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in DiaSorin SpA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
DiaSorin SpA Corporate Management
Elected by the shareholders, the DiaSorin SpA's board of directors comprises two types of representatives: DiaSorin SpA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DiaSorin. The board's role is to monitor DiaSorin SpA's management team and ensure that shareholders' interests are well served. DiaSorin SpA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DiaSorin SpA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fabrizio Bonelli | Chief Officer | Profile | |
| Ulisse Spada | Mang Department | Profile | |
| Angelo Rago | Pres Corp | Profile | |
| Ugo Gay | Sr Operations | Profile |
Other Information on Investing in DiaSorin Stock
DiaSorin SpA financial ratios help investors to determine whether DiaSorin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DiaSorin with respect to the benefits of owning DiaSorin SpA security.